Based on our evidence from Lysotracker assay, Au-Col-BB nanocarrier would not degrade under acidic condition and was stable, suggesting Au-Col-BB to be a potential nanodrug for targeting Her-2 breast carcinoma. The gene discussed is ERBB2; the disease is breast carcinoma.